These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23139239)

  • 1. Directed modulation of protein kinase C isozyme selectivity with bisubstrate-based inhibitors.
    van Wandelen LT; van Ameijde J; Mady AS; Wammes AE; Bode A; Poot AJ; Ruijtenbeek R; Liskamp RM
    ChemMedChem; 2012 Dec; 7(12):2113-21. PubMed ID: 23139239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of selective bisubstrate-based inhibitors against protein kinase C (PKC) isozymes by using dynamic peptide microarrays.
    Poot AJ; van Ameijde J; Slijper M; van den Berg A; Hilhorst R; Ruijtenbeek R; Rijkers DT; Liskamp RM
    Chembiochem; 2009 Aug; 10(12):2042-51. PubMed ID: 19618415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATP-conjugated peptide inhibitors for calmodulin-dependent protein kinase II.
    Ahn DR; Han KC; Kwon HS; Yang EG
    Bioorg Med Chem Lett; 2007 Jan; 17(1):147-51. PubMed ID: 17035012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-penetrating bisubstrate-based protein kinase C inhibitors.
    van Wandelen LT; van Ameijde J; Ismail-Ali AF; van Ufford HC; Vijftigschild LA; Beekman JM; Martin NI; Ruijtenbeek R; Liskamp RM
    ACS Chem Biol; 2013 Jul; 8(7):1479-87. PubMed ID: 23621550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Truncation and optimisation of peptide inhibitors of cyclin-dependent kinase 2-cyclin a through structure-guided design.
    Kontopidis G; Andrews MJ; McInnes C; Plater A; Innes L; Renachowski S; Cowan A; Fischer PM
    ChemMedChem; 2009 Jul; 4(7):1120-8. PubMed ID: 19472269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases.
    Comess KM; Sun C; Abad-Zapatero C; Goedken ER; Gum RJ; Borhani DW; Argiriadi M; Groebe DR; Jia Y; Clampit JE; Haasch DL; Smith HT; Wang S; Song D; Coen ML; Cloutier TE; Tang H; Cheng X; Quinn C; Liu B; Xin Z; Liu G; Fry EH; Stoll V; Ng TI; Banach D; Marcotte D; Burns DJ; Calderwood DJ; Hajduk PJ
    ACS Chem Biol; 2011 Mar; 6(3):234-44. PubMed ID: 21090814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase C isozymes and their selectivity towards ruboxistaurin.
    Tang S; Xiao V; Wei L; Whiteside CI; Kotra LP
    Proteins; 2008 Jul; 72(1):447-60. PubMed ID: 18214957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competitive inhibitors and allosteric activators of protein kinase C isoenzymes: a personal account and progress report on transferring academic discoveries to the clinic.
    Budas GR; Koyanagi T; Churchill EN; Mochly-Rosen D
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):1021-6. PubMed ID: 17956268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic characterization of novel pyrazole TGF-beta receptor I kinase inhibitors and their blockade of the epithelial-mesenchymal transition.
    Peng SB; Yan L; Xia X; Watkins SA; Brooks HB; Beight D; Herron DK; Jones ML; Lampe JW; McMillen WT; Mort N; Sawyer JS; Yingling JM
    Biochemistry; 2005 Feb; 44(7):2293-304. PubMed ID: 15709742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisubstrate inhibitors of protein kinases: from principle to practical applications.
    Lavogina D; Enkvist E; Uri A
    ChemMedChem; 2010 Jan; 5(1):23-34. PubMed ID: 19774589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2,6-Naphthyridines as potent and selective inhibitors of the novel protein kinase C isozymes.
    van Eis MJ; Evenou JP; Floersheim P; Gaul C; Cowan-Jacob SW; Monovich L; Rummel G; Schuler W; Stark W; Strauss A; von Matt A; Vangrevelinghe E; Wagner J; Soldermann N
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7367-72. PubMed ID: 22078216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A highly potent and selective PKCalpha inhibitor generated via combinatorial modification of a peptide scaffold.
    Lee JH; Nandy SK; Lawrence DS
    J Am Chem Soc; 2004 Mar; 126(11):3394-5. PubMed ID: 15025445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C (PKC) isozyme-specific substrates and their design.
    Kang JH; Toita R; Kim CW; Katayama Y
    Biotechnol Adv; 2012; 30(6):1662-72. PubMed ID: 22841933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta.
    Jirousek MR; Gillig JR; Gonzalez CM; Heath WF; McDonald JH; Neel DA; Rito CJ; Singh U; Stramm LE; Melikian-Badalian A; Baevsky M; Ballas LM; Hall SE; Winneroski LL; Faul MM
    J Med Chem; 1996 Jul; 39(14):2664-71. PubMed ID: 8709095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A peptide substrate-based affinity label blocks protein kinase C-catalyzed ATP hydrolysis and peptide-substrate phosphorylation.
    Ward NE; Pierce DS; Stewart JR; O'brian CA
    Arch Biochem Biophys; 1999 May; 365(2):248-53. PubMed ID: 10328819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization, anchoring, and functions of protein kinase C isozymes in the heart.
    Mackay K; Mochly-Rosen D
    J Mol Cell Cardiol; 2001 Jul; 33(7):1301-7. PubMed ID: 11437536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anchoring proteins for protein kinase C: a means for isozyme selectivity.
    Mochly-Rosen D; Gordon AS
    FASEB J; 1998 Jan; 12(1):35-42. PubMed ID: 9438408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the structure of adenosine mimic of bisubstrate-analog inhibitors on their activity towards basophilic protein kinases.
    Enkvist E; Kriisa M; Roben M; Kadak G; Raidaru G; Uri A
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6098-101. PubMed ID: 19800227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential for isoenzyme-selective modulation of protein kinase C.
    Hofmann J
    FASEB J; 1997 Jul; 11(8):649-69. PubMed ID: 9240967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in designing substrate-competitive protein kinase inhibitors.
    Han KC; Kim SY; Yang EG
    Curr Pharm Des; 2012; 18(20):2875-82. PubMed ID: 22571656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.